Submission Details
| 510(k) Number | K241165 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 26, 2024 |
| Decision Date | July 25, 2024 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K241165 is an FDA 510(k) clearance for the Atellica? IM High-Sensitivity Troponin I (TnIH), a Immunoassay Method, Troponin Subunit (Class II — Special Controls, product code MMI), submitted by Siemens Healthcare Diagnostics, Inc. (Newark, US). The FDA issued a Cleared decision on July 25, 2024, 90 days after receiving the submission on April 26, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K241165 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 26, 2024 |
| Decision Date | July 25, 2024 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |